NASDAQ
Evelo Biosciences, Inc. (EVLO) has a current ratio of 4.16x as of Monday, May 25, 2026. This represents a 47.46% decrease compared to its 12-month average of 7.92x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.